Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 308

1.

Nephroprotective Potential of Human Albumin Infusion: A Narrative Review.

Wiedermann CJ, Joannidis M.

Gastroenterol Res Pract. 2015;2015:912839. doi: 10.1155/2015/912839. Epub 2015 Jun 7. Review.

2.

The use of meta-analyses for benefit/risk re-evaluations of hydroxyethyl starch.

Wiedermann CJ.

Crit Care. 2015 Jun 2;19:240. doi: 10.1186/s13054-015-0940-7. No abstract available.

3.

Propensity matching cannot substitute for randomization in albumin studies.

Wiedermann CJ, Wiedermann W.

Crit Care. 2015 Apr 28;19:206. doi: 10.1186/s13054-015-0786-z. No abstract available.

4.
5.

[Adjuvant treatment of sepsis: what is known?].

Wiedermann CJ.

Med Klin Intensivmed Notfmed. 2014 Nov;109(8):583-90. doi: 10.1007/s00063-014-0379-7. Epub 2014 Oct 22. German.

PMID:
25330980
6.

Hydroxyethyl starch effects on tissue perfusion and oxygenation in patients undergoing liver surgery.

Wiedermann CJ.

Int J Clin Exp Med. 2014 Jun 15;7(6):1623. eCollection 2014. No abstract available.

7.

Albumin replacement in severe sepsis or septic shock.

Wiedermann CJ, Joannidis M.

N Engl J Med. 2014 Jul 3;371(1):83. doi: 10.1056/NEJMc1405675#SA1. No abstract available.

PMID:
24988572
8.

Reporting bias in trials of volume resuscitation with hydroxyethyl starch.

Wiedermann CJ.

Wien Klin Wochenschr. 2014 Apr;126(7-8):189-94. doi: 10.1007/s00508-014-0503-y. Epub 2014 Mar 5. Review.

9.

Imported visceral leishmaniasis - unexpected bone marrow diagnosis in a patient with fever, pancytopenia, and splenomegaly.

Gallina V, Binazzi R, Golemi A, Farsad M, Weiss G, Wiedermann CJ.

Am J Blood Res. 2014 Dec 15;4(2):101-5. eCollection 2014.

10.

High-volume hemofiltration in critically ill patients: a systematic review and meta-analysis.

Lehner GF, Wiedermann CJ, Joannidis M.

Minerva Anestesiol. 2014 May;80(5):595-609. Epub 2013 Nov 29. Review.

11.

Accumulation of hydroxyethyl starch in human and animal tissues: a systematic review.

Wiedermann CJ, Joannidis M.

Intensive Care Med. 2014 Feb;40(2):160-70. doi: 10.1007/s00134-013-3156-9. Epub 2013 Nov 21. Review.

PMID:
24257970
12.

Hydroxyethyl starch 130/0.4: safe for the kidney in surgical patients?

Wiedermann CJ.

Anesthesiology. 2013 Sep;119(3):735-6. doi: 10.1097/ALN.0b013e31829ff30f. No abstract available.

PMID:
23962943
13.

Concerns about renal safety of HES 130.

Wiedermann CJ, Joannidis M.

Crit Care. 2013 Aug 1;17(4):444. doi: 10.1186/cc12805. No abstract available.

14.

Chloride-restrictive fluid administration and incidence of acute kidney injury.

Wiedermann CJ, Joannidis M.

JAMA. 2013 Feb 13;309(6):543. doi: 10.1001/jama.2012.171508. No abstract available.

PMID:
23403666
15.

Increased mortality after infusion of "modern" hydroxyethyl starch.

Wiedermann CJ, Joannidis M.

Swiss Med Wkly. 2013 Jan 21;143:w13747. doi: 10.4414/smw.2013.13747. No abstract available.

16.

From persistence to palliation: limiting active treatment in the ICU.

Wiedermann CJ, Lehner GF, Joannidis M.

Curr Opin Crit Care. 2012 Dec;18(6):693-9. doi: 10.1097/MCC.0b013e328358d417. Review.

PMID:
22941210
17.

Sensory neuropathy in paraneoplastic leucocytosis.

Amor F, Bernardo M, Fattor B, Wiedermann CJ.

BMJ Case Rep. 2012 Aug 8;2012. pii: bcr2012006487. doi: 10.1136/bcr-2012-006487.

PMID:
22878999
18.

Mortality after hydroxyethyl starch 130/0.4 infusion: an updated meta-analysis of randomized trials.

Wiedermann CJ, Joannidis M.

Swiss Med Wkly. 2012 Jul 30;142:w13656. doi: 10.4414/smw.2012.13656.

19.

Effect of molecular weight and substitution on tissue uptake of hydroxyethyl starch: a meta-analysis of clinical studies.

Bellmann R, Feistritzer C, Wiedermann CJ.

Clin Pharmacokinet. 2012 Apr 1;51(4):225-36. doi: 10.2165/11594700-000000000-00000. Review.

PMID:
22420578
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk